Search
You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "Teva Pharmaceutical Industries Ltd.."
12 result(s) displayed (1 - 12 of 14)
The Israeli drug giant's CEO tells attendees at the JPMorgan Healthcare Conference that the company is surveying all nonlabor expenditures to find efficiencies that would yield cash it would use on fewer therapeutic areas. Continue reading
Posted on January 10, 2013 2:21 PM
The two German companies will collaborate on the development of three compounds for the female health malady over a five-year period under a deal that could be worth as much as $750 million. Continue reading
Posted on October 1, 2012 4:04 PM
The deal caps a long series of smaller acquisitions by the Canadian pharmaceutical company, which lost out in the bidding for Cephalon in May last year Continue reading
Posted on September 4, 2012 11:39 AM
The pharmaceutical company's share price is buoyed by takeover speculation after its Alzheimer's compound fails a clinical trial Continue reading
Posted on August 8, 2012 9:08 AM
The pharma company expands its generics business with its largest acquisition so far. Continue reading
Posted on April 26, 2012 11:24 AM
The pharma strikes a solid deal for what could be a revolutionary cancer drug. Continue reading
Posted on January 20, 2012 12:00 PM
Cephalon Inc. now has the novel distinction of changing the fortunes of two different global pharmaceutical companies on the same day. Continue reading
Posted on October 18, 2011 2:44 PM
The FTC clearance of the $6.8 billion takeover of Cephalon comes as the EC continues to review the transaction. Continue reading
Posted on October 10, 2011 11:17 AM
PE didn't exist in the country before 2005, and it has made great strides since then, but it remains far too small to attract heavyweights like KKR and Carlyle. Continue reading
Posted on September 30, 2011 1:00 PM
The generic drugmaker will pay Kowa $150 million as part of a plan to establish itself as a market leader in Japan. Continue reading
Posted on September 26, 2011 3:13 PM
Par Pharmaceutical Cos. said Wednesday, Aug. 24, that it will buy privately held rival Anchen Pharmaceuticals Inc. for $410 million in cash to extend its portfolio of generic products.The deal is part of a rush by generic drug manufacturers to... Continue reading
Posted on August 24, 2011 11:16 AM
Cephalon Inc.'s Actiq pain medication, administered as a lollipop, may be added to the list of products the U.S. Federal Trade Commission will require to be divested as a condition of antitrust approval for the company's $6.8 billion acquisition... Continue reading
Posted on August 11, 2011 4:47 PM
Movable Type search results powered by Fast Search
Todd P. Kelly joined the Dallas Office of Jones Day as a partner in the healthcare and life sciences practice. For other updates launch today's Movers & shakers slideshow.
The Jordan Co. managing director talks about manufacturing M&A with private equity senior editor Jonathan Marino. More video
